|
|
Tianyin Pharma Creates New Antibiotic JV
publication date: Oct 30, 2009
Tianyin Pharmaceutical has formed a joint venture with Sichuan Mingxin Pharmaceutical Co. to produce macrolide antibiotics, such as azithromycin, clarithromycin and roxithromycin. Tianyin will own 77% of the JV, which will be known as Sichuan Jiangchuan Pharmaceutical Co., Ltd. Although Tianyin was historically focused on TCM products, it received its first SFDA approval for an antibiotic, Azithromycin Dispersible Tablets, in 2008. More details... Stock Symbol: (NYSE Alternext: TPI)
|
ChinaBio® Events
April 14, 2010 Guangzhou, China Suzhou, China June 23-24, 2010
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|